Literature DB >> 3491325

Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence.

A R Townsend, J Bastin, K Gould, G G Brownlee.   

Abstract

A surprising feature of most cytotoxic T lymphocytes (CTL) responding to influenza infection is that they recognize the unglycosylated (non-transmembrane) proteins of the virus, including the nucleoprotein. Recognition of cells that express nucleoprotein by CTL does not depend on a definite signal sequence within the protein, and the epitopes recognized can be defined with short synthetic peptides in vitro. Haemagglutinin (HA), the major transmembrane protein of the virus, is recognized by a minor population of CTL from infected mice. We have deleted the sequence coding for the N-terminal signal peptide from a complementary DNA encoding HA of the H1 subtype. The signal-deleted HA is detected with antibodies as a short-lived, unglycosylated, intracellular protein. However, CTL raised to the complete molecule recognize cells expressing the signal-deleted HA and vice versa. These results cast doubts on the assumption that CTL recognize the HA molecule only after its insertion into the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491325     DOI: 10.1038/324575a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  74 in total

Review 1.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

Review 2.  Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease.

Authors:  A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1992

Review 3.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

4.  Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin.

Authors:  C E Hioe; N Dybdahl-Sissoko; M Philpott; V S Hinshaw
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.

Authors:  A Brooks; S Hartley; L Kjer-Nielsen; J Perera; C C Goodnow; A Basten; J McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes.

Authors:  Leonia Bozzacco; Christine Trumpfheller; Frederick P Siegal; Saurabh Mehandru; Martin Markowitz; Mary Carrington; Michel C Nussenzweig; Angela Granelli Piperno; Ralph M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

Review 7.  Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Authors:  Pavlo Gilchuk; Timothy M Hill; John T Wilson; Sebastian Joyce
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

8.  Mouse brain CD4 transcripts encode only the COOH-terminal half of the protein.

Authors:  N Lonberg; S N Gettner; E Lacy; D R Littman
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

9.  A new antigen recognized by anti-liver-kidney-microsome antibody (LKMA).

Authors:  P Codońer-Franch; K Paradis; M Gueguen; O Bernard; A A Costesec; F Alvarez
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

10.  Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.

Authors:  Yeping Sun; Jun Liu; Meng Yang; Feng Gao; Jianfang Zhou; Yoshihiro Kitamura; Bin Gao; Po Tien; Yuelong Shu; Aikichi Iwamoto; Zhu Chen; George F Gao
Journal:  J Gen Virol       Date:  2009-12-02       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.